![1]()
News
Three COVID-19 rapid diagnostic tests get FDA thumbs-up
March 24, 2020
One of the point-of-care tests can deliver results in 30 minutes, the remaining two, at 45 minutes.
![1]()
News
Reports increasingly suggest anosmia/hyposmia can signal early COVID-19 infection
March 24, 2020
But a WHO expert said the organization needs to look into whether anosmia is an early sign and symptom.
![1]()
News
High rate of asymptomatic COVID-19 seen in cruise ship passengers
March 24, 2020
Viral DNA found on surfaces in cabins 17 days after passengers left the Diamond Princess.
News
CDC coronavirus testing decision likely to haunt nation for months to come
March 24, 2020
Public health officials are just beginning to grapple with the fallout from a lack of early testing.
News
AMA offers resources for front-line physicians
March 24, 2020
The resources include practical tips for using telemedicine and an ethical guide for physicians.
![1]()
Opinion
Hand washing and hand sanitizer on the skin and COVID-19 infection risk
March 23, 2020
With regard to the effectiveness of hand washing against viruses, the length of time spent hand washing has been shown to have an impact on influenza-like illness.
Audio
How texting unites Seattle’s critical care departments
March 23, 2020
A basic smartphone feature becomes a crucial tool to keep the region’s ICUs connected.
News
Amid hydroxychloroquine hopes, lupus patients face shortages
March 23, 2020
Pharmacists are reporting depleted stocks of the drug, leaving many of the roughly 1.5 million lupus patients across the country unable to get their prescriptions filled. They now face an uncertain future as the public clings to one of the first signs of hope to appear since the coronavirus began sweeping across the U.S.
News
Webinar confronts unique issues for the bleeding disorders community facing COVID-19
March 23, 2020
Patients in gene therapy trials and those with factor inhibitors are of particular concern.
News
Should patients with COVID-19 avoid ibuprofen or RAAS antagonists?
March 23, 2020
Health agencies and professional organizations are not recommending against ibuprofen or other drugs such as renin angiotensin aldosterone system (RAAS) antagonists for COVID-19 patients.
